Corticospinal tract-sparing intensity-modulated radiotherapy treatment planning  by Igaki, Hiroshi et al.
reports of practical oncology and radiotherapy 1 9 ( 2 0 1 4 ) 310–316
Available  online  at  www.sciencedirect.com
jo ur nal home p ag e: ht tp : / /www.e lsev ier .com/ locate / rpor
Original research article
Corticospinal  tract-sparing  intensity-modulated
radiotherapy treatment  planning
Hiroshi Igakia,∗, Akira Sakumia, Akitake Mukasab, Kuniaki Saitob,
Akira  Kunimatsua, Yoshitaka Masutania, Shunya Hanakitab, Kenji Inoa,
Akihiro Hagaa, Keiichi Nakagawaa, Kuni Ohtomoa
a Department of Radiology, The University of Tokyo Hospital, Tokyo, Japan
b Department of Neurosurgery, The University of Tokyo Hospital, Tokyo, Japan
a  r  t  i  c  l  e  i  n  f  o
Article history:
Received 20 June 2013
Received in revised form
30  November 2013
Accepted 23 January 2014
Keywords:
Intensity-modulated radiotherapy
Diffusion tensor tractography
Corticospinal tract
Malignant glioma
Organ at risk
a  b  s  t  r  a  c  t
Aim: To establish intensity-modulated radiotherapy (IMRT) planning procedures that spare
the  corticospinal tract by integrating diffusion tensor tractography into the treatment plan-
ning  software.
Background: Organs at risk are generally contoured according to the outline of the organ as
demonstrated by CT or MRI. But a part of the organ with speciﬁc function is difﬁcult to pro-
tect, because such functional part of the organ cannot be delineated on CT or conventional
sequence of MRI.
Methods: Diagnostic and treatment planning images of glioblastoma patients who had been
treated by conventional 3-dimensional conformal radiotherapy were used for re-planning
of  IMRT. Three-dimensional ﬁber maps of the corticospinal tracts were created from the
diffusion tensors obtained from the patients before the surgery, and were blended with
the  anatomical MR images (i.e. gadolinium-enhanced T1-weighted images or T2-weighted
images). DICOM-formatted blended images were transferred and fused to the planning CT
images. Then, IMRT plans were attempted.
Results: The corticospinal tracts could be contoured as organs at risk (OARs), because the
blended images contained both anatomical information and ﬁber-tract maps. Other OARs
were contoured in a way similar to that of ordinary IMRT planning. Gross tumor volumes,
clinical target volumes, planning target volumes, and other OARs were contoured on the
treatment planning software, and IMRT plans were made.Conclusions: IMRT plans with diminished doses to the corticospinal tract were attained. This
technique enabled us to spare speciﬁc neuron ﬁbers as OARs which were formerly “invisible”
and  to reduce the probability of late morbidities.
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.  Background
ntensity-modulated radiotherapy (IMRT) is a technique that
pares OARs while maintaining a high dose to the planning
arget volume. In order to avoid radiation dose to certain areas
f the body in IMRT  planning, these areas have to be contoured
nd deﬁned as OARs on the treatment planning system. OARs
re generally contoured according to the outline of the organ
s demonstrated by CT or MRI. But a part of the organ with a
peciﬁc function is difﬁcult to protect, because the procedures
o fuse functional images to radiotherapy planning CT images
ave not been fully formulated.
Recent advances in imaging technologies have enabled us
o determine the brain areas of speciﬁc functions which are
ot visible in conventional CT or the conventional sequence
f MRI. One of the newer imaging technologies includes diffu-
ion tensor tractography. These images can depict the lineage
f neuron ﬁbers from the diffusion anisotropy of water in the
euronal axon. Using this method, the putative position of
peciﬁc neuron ﬁbers in the white matter, such as the cor-
icospinal tract, optic radiation, arcuate fasciculus, can be
nown.1–4 For patients with brain tumors who are under-
oing neurosurgery, operative procedures have become safe,
ncorporating diffusion tensor tractography into the preop-
rative workup, since neurosurgeons are able to know the
roximity of the tumor to the eloquent tract before surgery.5,6
t our hospital, diffusion tensor tractography has also been
used to Gamma  Knife treatment-planning MRIs, mainly for
atients with arteriovenous malformation, with good clinical
esults.3,4,7,8
Treatment results of malignant glioma are not satisfactory,
nd various attempts to improve radiation delivery have been
ade to prolong the patients’ survival. IMRT is one of the
rincipal technologies applied for better dose distribution,9
ecause the brain has many  OARs visible on planning CT or
n conventional MRI, such as the brainstem, optic pathways,
yeballs, and hippocampus. However, invisible parts, like spe-
iﬁc neuron ﬁbers, should be considered as OARs to reduce
he morbidity rate, especially when a higher dose delivery is
ntended.
.  Aim
n this study, we tried to deﬁne the corticospinal tract as an
AR by fusing diffusion tensor tractography into the planning
T to diminish the dose to the corticospinal tract and use the
esult to conduct IMRT  planning of patients with malignant
lioma.
.  Materials  and  methods
.1.  Patients  and  imaging  studiesigh-grade glioma patients with pathological diagnosis con-
rmed by stereotactic biopsy who  had been treated by
0 Gy of 3-dimensional conformal radiotherapy with con-
urrent and adjuvant temozolomide were selected. Theirtherapy 1 9 ( 2 0 1 4 ) 310–316 311
diagnostic images and treatment-planning images, respec-
tively, were used for IMRT planning.
Diffusion tensor tractography was constructed as shown
previously.1,7 In brief, diffusion-weighted images were
acquired at 1.5 T using a head coil with echo planar capa-
bility, by a single-shot spin echo-echo planar sequence
(TR 6000 ms,  TE 78 ms)  before stereotactic biopsy. Diffusion
tensors were then calculated and 3-dimensional ﬁber-tract
maps were created using the free software dTV. The soft-
ware was developed by the Image  Computing and Analysis
Laboratory at the Department of Radiology of the Univer-
sity of Tokyo Hospital, Japan, and is available online at
http://www.ut-radiology.umin.jp/people/masutani/dTV.htm.
A region of interest was manually drawn as seeds on an
uninvolved region of the corticospinal tract that could be
detected in the cerebral peduncle on the anatomical MR  image
(gadolinium-enhanced T1-weighted images or T2-weighted
images), and another region of interest on the ipsilateral
precentral gyrus as a target. Diffusion tensor tractography
was reconstructed in 3-dimensional space from the seeds
along the major eigenvector to trace axonal projections, and
only the tracts reaching the target were displayed. Tracking
was terminated when it reached a pixel with a fractional
anisotropy lower than 0.18. Three-dimensional ﬁber-tract
maps were made by marking the voxels running through
the tract. The anatomical images and ﬁber-tract maps were
blended, and the blended images were re-sliced and con-
verted to the DICOM format by image  processing software Dr.
View (AJS Co. Ltd., Tokyo, Japan).
3.2.  Image  fusion  and  treatment  planning
Treatment planning CT images were obtained with the
head ﬁxed by a thermo-plastic shell. Blended tractogra-
phy images were fused to treatment planning CT images
on a treatment planning system. The corticospinal tract
that was displayed on the blended images was contoured
manually on the treatment planning system and deﬁned
as an OAR. Gadolinium-enhanced T1-weighted images, T2-
weighted images, or ﬂuid-attenuated inversion recovery
images were also fused to the planning CT in order to con-
tour other OARs, gross tumor volumes, and clinical target
volumes (CTVs). The eyeballs, lenses, optic pathways, and
brainstem were contoured as OARs. CTV1 was deﬁned as a
perifocal edema with a 15-mm margin, and CTV2 was the
tumor enhanced with gadolinium on MRI. PTV1 and PTV2 were
deﬁned as the corresponding CTVs plus 5-mm margins, and
IMRT  plans were made by the Pinnacle3 treatment-planning
system (Philips/ADAC, Milpitas, CA) to deliver 50 Gy to PTV1
and 65 Gy to PTV2 by the simultaneous integrated boost
method in 25 fractions. Dose constraints are shown in Table 1.
For comparison to the conventional IMRT plan, another IMRT
plan was made under the same sets of dose constraints but
without that for the corticospinal tract.4.  Results
Blended tractography images containing anatomical infor-
mation and ﬁber-tract maps were constructed (Fig. 1). The
312  reports of practical oncology and rad
Table 1 – Dose constraints for IMRT  plans.
Regions of interest Dose constraints
PTV1 D95% > 50 Gy
PTV2 D95% > 65 Gy
Brainstem V54  Gy < 10%
Corticospinal tract Max 50 Gy
Optic tract Max  50 Gy
onwards, while such change was not detectable within the
dose level under 60 Gy in the gray matter. In the spinalEyes Max 30 Gy
blended images were transferred to the treatment-planning
system and fused to the planning CT images in accor-
dance with the anatomical information contained in the
blended images. The corticospinal tract ﬁbers were contoured
in the blended images, because they are depicted on the
blended images of Fig. 1C. As a consequence, the corticospinal
tract could be registered as an OAR on the treatment plan-
ning system, like other OARs such as eyeballs, chiasm, and
brainstem.
IMRT planning was performed according to the planning
objectives shown in Table 1. The plan was compared with
another IMRT  plan made with similar combinations of the
planning objectives in Table 1, but without the dose constraint
for the corticospinal tract (Fig. 2). Dose–volume histogram
(DVH) analyses revealed marked dose reduction in the corti-
cospinal tract by integrating tractography into IMRT planning
(Table 2 and Fig. 3).
Fig. 1 – Blended image processing. Corticospinal tract passages w
Gadolinium-enhanced T1 weighted images were obtained under
corticospinal tract images were merged into new images contain
passages of the corticospinal tract (C) by image processing softwiotherapy 1 9 ( 2 0 1 4 ) 310–316
5.  Discussion
On IMRT planning, various kinds of imaging modalities have
been used for image  fusion for precise deﬁnition of gross
tumor volumes, clinical target volumes, or OARs. Many  new
imaging techniques of MRI have been invented, not only for
better tissue resolution but also for visualization of compo-
nents with speciﬁc functions within organs that have been
“invisible” in CT or conventional-sequence MRI. One of these
techniques includes diffusion tensor images. In this paper, we
proposed a new IMRT planning technique that can decrease
the dose to the corticospinal tract by fusing diffusion tensor
tractography into the treatment planning CTs of patients with
malignant glioma.
The white matter of the brain is more  vulnerable to
radiation than the gray matter when the changes are eval-
uated clinically, pathologically, or radiologically.10–20 Steen
et al. studied the effect of therapeutic radiation on the cen-
tral nervous system in pediatric brain tumor patients.10,11
Their quantitative MRI  analyses revealed that a radiation
dose greater than 30 Gy was associated with a spin-lattice
relaxation time decrease in the white matter in a dose-
and time-dependent manner 3 months after radiotherapycord, experimental radiation injuries were also more  sever
in the white matter than in the gray matter.14–17 Though a
ere  extracted from the diffusion tensor image (A).
 the common spatial coordinate axis (B) and the
ing anatomic information of the brain with clearly visible
are Dr. View.
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Fig. 2 – IMRT  plans that protect the corticospinal tract. (A) An IMRT  plan of case 1. Doses to bilateral corticospinal tracts were
constrained under 50 Gy. (B) Another IMRT  plan of case 1, made under the same sets of dose constraints but without that for
the corticospinal tract using the same CT images as in A. (C) An IMRT  plan of case 2 with the dose constraints for the
corticospinal tracts. (B) Another IMRT  plan of case 2 without the dose constraints for corticospinal tract using the same CT
images as in C. PTV1 and PTV2 are portrayed in light green and orange, respectively; corticospinal tracts are portrayed in
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herapeutic radiation dose of less than 50 Gy seldom induces
linically apparent impairment of neurocognitive or motor
unction, vascular and glial injuries can occur by a lower dose
f radiation in the white matter.18–20 The rationale of our
trategy of protecting axonal ﬁbers by tractography-integrated
MRT is based on these ﬁndings.
It has been well recognized that gross tumor volumes or
linical target volumes should be deﬁned not only by anatom-
cal structures that can be contoured by CT or conventional
equences of MRI  but also by structures that are delineated by
he functional imaging of positron emission tomography.21–26
hang et al. have reported IMRT  that spares the primary motor
ortex by the fusing of functional MRI  to the planning CT.27–29
owever, similar strategies of protecting OARs by fusing func-
ional images have not well been established.
We  have used diffusion tensor tractography in Gamma
nife treatment planning of patients with arteriovenousmalformation to decrease the dose to critical structures, such
as the corticospinal tract, optic radiation, or arcuate fascicu-
lus since 2004.3,4,7 In our Gamma  Knife experience, the rate of
delayed motor complications was high among the arteriove-
nous malformation patients whose corticospinal tract dose
was proved to be high by retrospective integration of diffu-
sion tensor tractography into the dose distributions of Gamma
Knife treatment plans.30 In addition, neurological morbidi-
ties after treatment were decreased by avoiding high-dose
delivery to the visualized ﬁber tract through the prospective
integration of diffusion tensor tractography into the Gamma
Knife treatment planning.8 Our observations have three sig-
niﬁcant implications. The ﬁrst is that functional structures
such as neuron ﬁbers that were “invisible” previously in the
CT or conventional MRI should be protected in order to reduce
post-treatment complications. The second is that the local-
ization of the neuron ﬁbers depicted on the diffusion tensor
314  reports of practical oncology and radiotherapy 1 9 ( 2 0 1 4 ) 310–316
Table 2 – Dose–volume statistics of the plans.
Volume Index Case 1 Case 2a
With constraint
for CST
Without
constraint for CST
With constraint
for CST
Without
constraint for CST
Figs. 2A and 3A
(solid line)
Figs. 2B and 3A
(dotted line)
Figs. 2C and 3B
(solid line)
Figs. 2D and 3B
(dotted line)
PTV1 D98% (cGy) 6951 6768 6782 6798
Dmean (cGy) 6802 6711 6697 6699
D2% (cGy) 6438 6518 6460 6500
PTV2 D98% (cGy) 6573 6481 6440 6427
Dmean (cGy) 5564 5480 5519 5485
D2% (cGy) 4648 4915 4802 4960
CST-R D98% (cGy) 4461 5593 – –
Dmean (cGy) 3860 5039 – –
V50  Gy (%) 0  71.99 –  –
V40  Gy (%) 28.89 96.57 –  –
V30  Gy (%) 96.87 97.74 – –
CST-L D98% (cGy) 4678 5255 4653 5492
Dmean (cGy) 3990 4743 2597 2936
V50  Gy (%) 0.02 16.41 0 20.19
V40  Gy (%) 55.95 95.1 44.18 50.74
V30  Gy (%) 96.27 97.84 53.51 53.94
PTV = planning target volume; CST = corticospinal tract; D98% = dose to 98% of the volume; Dmean = mean dose of the volume; D2% = dose to 2% of
the volume; V50  Gy = % volume receiving a dose over 50 Gy; V40  Gy = % volume receiving a dose over 40 Gy; V30  Gy = % volume receiving a dose over
cs be
30 Gy.
a Right corticospinal tract was not analyzed for dose–volume statisti
tractography is sufﬁciently reliable for clinical decision mak-
ing in Gamma  Knife treatment. Finally, clinical application of
these tractography-based ﬁber-sparing techniques is feasible
in the Gamma  Knife treatment planning system.
After experiencing tractography-based ﬁber-sparing
Gamma  Knife treatment of arteriovenous malformation, we
tried to apply these methods for another disease. Appropriate
extent of clinical target volume for malignant glioma is contro-
versial and its deﬁnitions are different among hospitals.31,32Therefore, we  expected lower rate radiation morbidities due
to corticospinal tract injury without increasing the proba-
bility of local recurrences, by applying tractography-based
Fig. 3 – DVHs of IMRT  plans. DVHs of IMRT  plans of the case 1 (A
represent the plans with dose constraints for the corticospinal tr
(Fig. 2B and D), respectively. DVH analyses revealed that the dose
diminished by integrating tractography into IMRT  planning, whi
orange, green, purple, pink, and light blue lines represent DVHs 
corticospinal tract (CST-L), brainstem, and optic tract, respectivelcause of its sufﬁcient distance from the PTV.
ﬁber-sparing IMRT procedures to the treatment planning for
malignant gliomas.
One of the main limitations of this study is that the
clinical signiﬁcance of tractography has not been vali-
dated. Clinical validation of diffusion tensor tractography
has been attempted by electrophysiological procedures in
neurosurgical series,33–35 integrating functional MRI,36–38 and
comparisons with known anatomical connectivity or tracer
studies.39–42 Notably, Kamada et al. conﬁrmed the reliability
of diffusion tensor imaging-based tractography by showing
a strong correlation between the stimulus intensity of direct
ﬁber stimulation during operation and the distance from the
) and case 2 (B) shown in Fig. 2. Solid and dotted lines
act (Fig. 2A and C) and those without dose constraints
s to the corticospinal tracts and the brainstem were
le PTV dose coverages were comparable. Light green,
of PTV1, PTV2, right corticospinal tract (CST-R), left
y.
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timulus point to the corticospinal tract on tractography-
ntegrated neuronavigation images.33 But the size and the
xtent of the ﬁber bundle are not necessarily reliable, because
ber-tracking is dependent on various kinds of factors such as
patial resolution and signal-to-noise ratio of the images, the
econstruction algorithm, the size and location of the region
f interest drawn as seed and target, the threshold of frac-
ional anisotropy, and the existence of crossing ﬁbers.10,38,43–45
here is no gold standard for the ﬁber-tracking technique. In
his sense, we  should carefully re-evaluate the clinical use-
ulness of this method when the tract-tracking conditions
re different. Nevertheless, we believe that our experience
f tractography-integrated Gamma  Knife offers reliable infor-
ation on the localization accuracy of the functional axonal
bers.8,30
Another limitation of this study is the uncertainty of
herapeutic impact in terms of late radiation morbidity and
ocal tumor control, because this is not a clinical study but
nly a treatment-planning study of a very limited number
f patients. The patients whom this technique is applica-
le to are somewhat limited. The distance between the GTV
nd the corticospinal tract should not be too close, because
he dose to the corticospinal tract that is at a very high risk
f recurrences cannot be lowered. On the other hand, there
s no need to avoid corticospinal tract by IMRT when it is
t a sufﬁcient distance from the GTV. However, a portion of
atients, in fact, develop late neurotoxicities related to white
atter changes after IMRT.46,47 In addition, many  institutions
re adopting a simultaneous integrated boost IMRT technique
ith an accelerated fractionation schedule48,46,49–51 for the
reatment of malignant glioma, which potentially leads to an
ncreased rate of late radiation morbidities compared with
onventionally fractionated 3-dimensional conformal radio-
herapy, because the alpha/beta ratio of normal brain tissue
s known to be low. Dose reduction in the speciﬁc neu-
on ﬁbers by tractography-integrated IMRT might allow to
void such toxicities, even if there were limited number of
atients who received beneﬁts from corticospinal tract spar-
ng IMRT.  Viewing the feature of tract avoidance from another
ngle, local tumor control might be sacriﬁced. We selected
atients whose corticospinal tract was not involved by the
ross tumor (gadolinium-enhanced region) in this study; thus,
he dose to the gross tumor volume was not diminished
ue to corticospinal tract sparing (Fig. 3). In this respect,
e handled the corticospinal tract similarly as we  would
ther “visible” OARs during the treatment planning. Therefore,
e are now planning to test the feasibility and the efﬁcacy
f CST-sparing IMRT for glioblastoma patients in a clinical
rial.
.  Conclusions
e  developed corticospinal tract-sparing IMRT  plans for
atients with glioblastoma by integrating diffusion tensor
ractography into the treatment-planning system. Applica-
ion of this technique to IMRT  planning may limit the
ose to the corticospinal tract in patients with malignant
lioma.
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